GLP-1 drugs do not fit every patient
That vantage point gives the company a close view of the cost, access, and everyday decisions behind the GLP-1 conversation
Niacinamide is generally well tolerated at the doses present in compounded tirzepatide, but some individuals may experience mild flushing or warmth shortly after injection
Under this deal, Novo Nordisk has gained exclusive rights to develop and commercialize the drug outside of mainland China and its territories.
By Katie Chlada, Managing Director, Strategic Communications & Advisory Services, M+C Saatchi While everyone in marketing is fixated on AI, another shift is already changing how people live, eat, travel and age and its far more tangible in the short term
Weight loss may be another risk factor